GAD1 and schizophrenia: This hypothesis is supported by the postmortem literature showing that schizophrenia patients relative to controls show lower mRNA and protein levels of the synthetic enzyme GAD67 [4], lower levels of the GABA membrane transporter (GAT1) [5], and lower expression and cell density of GABAergic interneurons relative to controls [3, 6].